You are here

A Study In Patients With Advanced Solid Tumor

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Kobe-shi, Hyogo-ken, Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Neoplasms
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients histologically or cytologically diagnosed with advanced solid tumors

- Patients for whom standard therapies have not been effective, or for whom there are no
suitable therapies

- Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0, 1 or 2

- Patients with no uncontrolled hypertension

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients who have central lung lesions involving major blood vessels

- Patients who require anticoagulant therapy.

- Patients with active epilepsy seizure or symptoms, with brain metastases requiring
treatment, with spinal cord compression and with carcinomatous meningitis.

NCT00726752
Pfizer
Completed
A Study In Patients With Advanced Solid Tumor

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Melanoma, Skin Neoplasms
NCT00094107
All Genders
18+
Years
Multiple Sites
Neoplasms
NCT00195247
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now